COMMENTARY
Toward a New Understanding of Cancers in Adolescents and Young Adults
by Dr. Brandon Hayes-Lattin
My personal motivation to improve the understanding and care of cancer among adolescents and young adults (AYAs) comes from reflection on my own diagnosis of a prototypical young adult cancer, testicular cancer, at age 28. Read more > >
Cancer Research Now: Adolescent and Young Adult Cancers
Cancer researchers, advocates, and a cancer survivor introduce the topic of adolescent and young adult (AYA) cancers.
FEATURES
Uncovering the Biology of Cancers in Adolescents and Young Adults
Do cancers in teens and young adults have unique features?Clinical Trials Offer a Path to Better Care for AYAs with Cancer
Researchers and navigators aim to boost AYA trial enrollment to improve outcomesFor Many Young Cancer Survivors, Late Effects Pose Lasting Problems
Raising awareness, effective monitoring needed for population at risk for late effects of treatmentAYAs Are Not Alone: Confronting Psychosocial Challenges of Cancer
Myriad resources are available to meet the unique and specific psychosocial needs of AYAs with cancer
A Conversation with Matthew Zachary: The Young Adult Cancer Movement
Matthew Zachary, a survivor of young adult cancer, talks about his experience and how it inspired him to set up an organization to help other AYAsNCI Information and Resources for AYAs with Cancer
Information about treatment, clinical trials, support options, research, and other topics on cancers in adolescents and young adultsA Snapshot of AYA Cancers
Key information on AYA cancer incidence and mortality, relevant research activities, and recent scientific advances
HIGHLIGHTSSUPPLEMENT TO THE SPECIAL ISSUE
Breast Cancer Cells Found by Immunochemistry in Sentinel Nodes Not Associated with Survival
Technique doesn't aid prognosis and is unlikely to change treatment approachRadiation Plus Short-Term Hormone Therapy Improves Survival of Men with Early-Stage Prostate Cancer
Overall survival was significantly improved compared with radiation therapy aloneIn Hodgkin Lymphoma Study, Side Effects Distinguish Treatments
Clinical trial finds two treatment strategies to be equally effective
UPDATESSUPPLEMENT TO THE SPECIAL ISSUE
FDA Update
- Advisory Panel Recommends Accelerated Approval for Brentuximab
Notes
- NCI Director to Hold Town Hall Meeting
- NCI Translational Science Meeting Sessions to Be Videocast
- Thai Princess Signs Agreement with NCI
- NCI's Early Detection Research Network Wins NASA Award
- Noted Author and Oncologist Siddhartha Mukherjee Speaks at NIH
- Latest Issue of CCR Connections Released
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
